PLK1 and ovarian carcinoma: PLK1 is overexpressed in various cancer, including breast cancer, non-small cell lung cancer, colorectal cancer, prostate cancer, pancreatic cancer, melanoma, ovarian cancer, non-Hodgkin’s lymphomas, and acute myeloid leukemia (AML) [10].